Sanigen Co. Ltd (KOSDAQ:188260)
South Korea · Delayed Price · Currency is KRW 1,702.00
-5.00 (-0.29%)
At close: Feb 20, 2026
Sanigen Co. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 18,722 | 15,428 | 20,187 | 26,758 | 25,221 | 23,487 |
Other Revenue | -0 | - | - | -0 | -0 | - |
| 18,722 | 15,428 | 20,187 | 26,758 | 25,221 | 23,487 | |
Revenue Growth (YoY) | -0.74% | -23.57% | -24.56% | 6.09% | 7.38% | 15.92% |
Cost of Revenue | 15,581 | 13,191 | 17,526 | 23,057 | 21,812 | 20,154 |
Gross Profit | 3,141 | 2,237 | 2,661 | 3,701 | 3,409 | 3,333 |
Selling, General & Admin | 5,088 | 5,525 | 6,236 | 5,675 | 4,314 | 3,622 |
Research & Development | 2,110 | 2,087 | 2,294 | 1,691 | 1,591 | 1,453 |
Amortization of Goodwill & Intangibles | 17.72 | 19.59 | 24.79 | 27.49 | 14.16 | 17.93 |
Other Operating Expenses | 22.37 | 24.56 | 32.38 | 26.51 | 22.18 | 29.74 |
Operating Expenses | 8,280 | 8,827 | 9,447 | 7,783 | 6,275 | 5,388 |
Operating Income | -5,139 | -6,589 | -6,786 | -4,082 | -2,866 | -2,055 |
Interest Expense | -137.64 | -206.98 | -437.28 | -1,413 | -907.81 | -484.85 |
Interest & Investment Income | 101.05 | 257.42 | 172.06 | 77.56 | 27.76 | 38.89 |
Currency Exchange Gain (Loss) | 0.3 | 0.28 | 0.24 | -11.91 | 0.02 | -7.38 |
Other Non Operating Income (Expenses) | -13.22 | 21.61 | -2,253 | 1,379 | -533.54 | -328.01 |
EBT Excluding Unusual Items | -5,188 | -6,517 | -9,304 | -4,051 | -4,279 | -2,836 |
Gain (Loss) on Sale of Investments | - | 0.29 | 0.35 | -0.59 | -1.28 | -4.67 |
Gain (Loss) on Sale of Assets | - | -30.58 | - | -13.77 | -0.35 | 247.27 |
Pretax Income | -5,188 | -6,547 | -9,304 | -4,065 | -4,281 | -2,593 |
Income Tax Expense | 1.23 | 8.3 | -58.05 | - | - | - |
Earnings From Continuing Operations | -5,190 | -6,555 | -9,246 | -4,065 | -4,281 | -2,593 |
Minority Interest in Earnings | - | - | - | - | - | -1.34 |
Net Income | -5,190 | -6,555 | -9,246 | -4,065 | -4,281 | -2,595 |
Net Income to Common | -5,190 | -6,555 | -9,246 | -4,065 | -4,281 | -2,595 |
Shares Outstanding (Basic) | 7 | 7 | 5 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 7 | 7 | 5 | 3 | 3 | 3 |
Shares Change (YoY) | 5.39% | 36.06% | 89.84% | 4.04% | 2.83% | 0.14% |
EPS (Basic) | -730.31 | -945.31 | -1814.00 | -1514.00 | -1659.00 | -1034.00 |
EPS (Diluted) | -730.31 | -945.31 | -1814.00 | -1514.00 | -1659.00 | -1034.00 |
Free Cash Flow | -4,695 | -5,773 | -4,049 | -6,220 | -3,011 | -1,442 |
Free Cash Flow Per Share | -660.66 | -832.54 | -794.37 | -2316.61 | -1166.98 | -574.73 |
Gross Margin | 16.78% | 14.50% | 13.18% | 13.83% | 13.52% | 14.19% |
Operating Margin | -27.45% | -42.71% | -33.62% | -15.26% | -11.36% | -8.75% |
Profit Margin | -27.72% | -42.49% | -45.80% | -15.19% | -16.97% | -11.05% |
Free Cash Flow Margin | -25.08% | -37.42% | -20.06% | -23.24% | -11.94% | -6.14% |
EBITDA | -4,203 | -5,634 | -5,827 | -3,271 | -2,263 | -1,524 |
EBITDA Margin | -22.45% | -36.52% | -28.87% | -12.22% | -8.97% | -6.49% |
D&A For EBITDA | 936.37 | 955.07 | 959.35 | 811.51 | 602.87 | 531.01 |
EBIT | -5,139 | -6,589 | -6,786 | -4,082 | -2,866 | -2,055 |
EBIT Margin | -27.45% | -42.71% | -33.62% | -15.26% | -11.36% | -8.75% |
Advertising Expenses | - | 302.27 | 285.21 | 180.98 | 72.31 | 54.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.